Ana María Perez Castillo

Title: Innovations of Ana María Perez Castillo in Neurodegenerative Disease Treatment

Introduction

Ana María Perez Castillo is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can potentially treat neurodegenerative diseases. Her work focuses on innovative solutions that address critical health challenges.

Latest Patents

Ana María holds a patent for "Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases." This invention is centered around a broad family of 5-imino-1,2,4-thiadiazoles, which are proposed as potential new drugs for treating diseases where PDE7 inhibition is crucial. These include inflammatory diseases, autoimmune disorders, and neurodegenerative conditions. The patent details the synthetic procedures for these compounds, highlighting their potential as drug candidates.

Career Highlights

Ana María is affiliated with the Consejo Superior de Investigaciones Científicas, a leading research institution in Spain. Her work has been instrumental in advancing the understanding and treatment of complex diseases. With her innovative approach, she has positioned herself as a key figure in pharmaceutical research.

Collaborations

Ana María has collaborated with notable colleagues, including Ana Martínez Gil and Carmen Gil Ayuso-Gontan. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in drug development.

Conclusion

Ana María Perez Castillo's contributions to the field of neurodegenerative disease treatment through her innovative patents exemplify the impact of dedicated research and collaboration. Her work continues to pave the way for new therapeutic options that could significantly improve patient outcomes.